FDA Expands Eye Drop Recall

(VitalNews.org) – Federal safety regulators have expanded their recall of eye drops in response to potential bacterial contamination issues found in the products. CVS, Rite Aid, Target, and Walmart are among the retailers affected by the recall, warning customers against using the tainted eye drops that could lead to eye infections, partial vision loss, or even blindness. The FDA raised concerns about the safety of eye drops manufactured by Kilitch Healthcare India Limited, citing unsanitary conditions in the production facility.

These safety concerns prompted retailers like CVS, Rite Aid, and Target to pull the affected eye drop products from their shelves and websites. Amazon also reacted by removing seven eye drop products after receiving a warning from the FDA about distribution violations and public health risks.

This is part of a series of recalls involving eye drop products throughout 2023, including previous warnings regarding specific brands, such as Dr. Berne’s MSM Drops 5% Solution, LightEyez MSM Eye Drops – Eye Repair, among others. The FDA’s vigilance in ensuring eye drop safety follows earlier investigations, such as one involving Global Pharma Healthcare in India, which led to rare bacterial infections and tragic consequences, including four deaths and severe vision issues among patients.

Experts emphasize the importance of using sterile eye drops and checking for potential recalls through the FDA’s updated list or the manufacturer’s website. Dr. Christopher Starr, a spokesperson for the American Academy of Ophthalmology, recommends seeking immediate medical assistance for any adverse reactions, such as discharge, redness, or pain, as these could indicate an infection. Consumers with inquiries about the recall can contact the manufacturers for further information.

The heightened concern over bacterial contamination in eye drops has prompted a wide-ranging recall by federal regulators. Retailers such as CVS, Rite Aid, Target, and Walmart have taken swift action, removing affected eye drop products from their stores and websites to ensure customer safety. This proactive step aligns with the FDA’s stringent measures to safeguard public health against potential eye infections and vision-related complications arising from tainted eye drop use.

Copyright 2023, VitalNews.org